quinagolide and Pseudotumor-Cerebri

quinagolide has been researched along with Pseudotumor-Cerebri* in 1 studies

Other Studies

1 other study(ies) available for quinagolide and Pseudotumor-Cerebri

Article	Year
Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:3 The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide). Topics: Adult; Aminoquinolines; Cerebrovascular Circulation; Dopamine Agents; Female; Humans; Hyperprolactinemia; Migraine Disorders; Pseudotumor Cerebri; Substance Withdrawal Syndrome	1994

Article

Year

Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist.

Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:3

The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).

Topics: Adult; Aminoquinolines; Cerebrovascular Circulation; Dopamine Agents; Female; Humans; Hyperprolactinemia; Migraine Disorders; Pseudotumor Cerebri; Substance Withdrawal Syndrome

1994